The groundbreaking treatment of this peptide represents a significant development in the care of the condition. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide114789.bloggazzo.com/40697004/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment